Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil

European Journal of Neurology

Volumn 18, Issue 12, 2011, Pages

  Pirker, S ^a   Baumgartner, C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBAMAZEPINE; CLOBAZAM; DIGITOXIN; ETIRACETAM; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; PHENYTOIN; PROTHIPENDYL; VALPROIC ACID; VERAPAMIL;

BASAL CELL CARCINOMA; BRAIN ISCHEMIA; CANCER SURGERY; CHRONIC KIDNEY FAILURE; CLONIC SEIZURE; COLON CARCINOMA; CONSCIOUSNESS DISORDER; DECUBITUS; DEMENTIA; DEPRESSION; DRUG DOSE INCREASE; EPILEPTIC STATE; FACE; FOCAL EPILEPSY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEEL; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LETTER; MIDDLE CEREBRAL ARTERY; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; SACRUM; SHOULDER; STOMACH TUBE;

AGED, 80 AND OVER; ANTICONVULSANTS; ASPIRIN; CARDIOVASCULAR DISEASES; DEMENTIA; DIGITOXIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSY, PARTIAL, MOTOR; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFARCTION, POSTERIOR CEREBRAL ARTERY; KIDNEY FAILURE, CHRONIC; P-GLYCOPROTEIN; STATUS EPILEPTICUS; VERAPAMIL;

EID: 81855206182     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03513.x     Document Type: Letter

References (3)

1. Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005; 6: 591-602.
2. Summers MA, Moore JL, McAuley JW. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Ann Pharmacother 2004; 38: 1631-1634.
3. Iannetti P, Spalice A, Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005; 46: 967-969.